@article{70124e541fcd4081b5b8650c6547a7d5,
title = "Anthracycline cardiotoxicity: The importance of horizontally integrating pre-clinical and clinical research",
author = "Lipshultz, {Steven E.} and Herman, {Eugene H.}",
note = "Funding Information: Dr. Lipshultz{\textquoteright} work has been supported in part by grants from the National Institutes of Health (HL072705, HL078522, HL053392, CA127642, CA068484, HD052104, AI50274, CA127642, CA068484, HD052102, HD052104, HL087708, HL079233, HL004537, HL087000, HL007188, HL094100, HL095127, HD80002, HD028820), Pfizer, Roche Diagnostics, the Children{\textquoteright}s Cardiomyopathy Foundation, Sofia{\textquoteright}s Hope, Inc., the Kyle John Rymiszewski Foundation, the Children{\textquoteright}s Hospital of Michigan Foundation, the Scott Howard Fund, and the Michael Garil Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",
year = "2018",
month = feb,
doi = "10.1093/cvr/cvx246",
language = "English (US)",
volume = "114",
pages = "205--209",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "2",
}